Создана биологическая модель лейкопении и торможения роста опухоли, вызванной 3-кратным введением циклофосфана в дозе 83,3мг/кг у мышей с карциномой лёгких Льюис (LLC) на 6-е, 12-е, 18-е сутки после трансплантации опухоли. Показано, что 3-кратное использование цитостатика приводит к ингибиции роста первичного опухолевого и метастазов. Кроме того, курсовое применение циклофосфана вызывает продолжительное угнетение гранулоцитарного и лимфоидного ростков кроветворения.
A new biological model of moderate inhibition of tumor growth and metastases with prolonged leukopenia on C57Bl/6 mice with the Lewis Lung Carcinoma was designed. The model was created by the injection of cyclophosphamide (dose 83.3mg/kg) on 6th, 12th, 18th days after tumor cells transplantation on animals. Experiment showed that 3-fold cyclo-phosphamide use leads to growth of primary tumor and metastases inhibition. Tumor growth inhibition was 34% on 21st day after cyclophosphamide inject. The number of metastases decreased by 4.7times (p<0,01). Metastatic area reduced. Metastasis frequency made 100%. In addition, the course of cyclophosphamide application caused inhibition of granulocytic and lymphoid hematopoiesis. The reducing the number of segmented neutrophils and lymphocytes was showed on the 3rd day after 1, 2 and 3 injections of cyclophosphamide. The model can be used to study the efficacy of drugs in tumor therapy and in correction of such toxic manifestation of chemotherapy as leukopenia.